Venclexta 100 mg Alternative – Venclax (Venetoclax) 100 mg Tablet | Beacon Pharmaceuticals
Venclax 100 mg (Venetoclax) Tablet by Beacon Pharmaceuticals. Reference brand: Venclexta. BCL-2 inhibitor; used in selected chronic lymphocytic leukemia and acute myeloid leukemia. Prescription medicine. Brand comparison does not establish interchangeability.
Product Overview
Venclax 100 mg Tablet is listed in the supplied Beacon Pharmaceuticals anti-cancer and hematology price list. The stated active ingredient is Venetoclax. Venclexta is a reference brand for the generic ingredient. This is a product-identification comparison, not a claim of verified bioequivalence or interchangeability.
Venclax vs Venclexta – Reference Brand Comparison
Venclexta is a recognized reference brand associated with Venetoclax. Venclax is listed under Beacon Pharmaceuticals. Their excipients, marketing authorizations, formulation details and regulatory evidence may differ. A clinician or pharmacist must confirm whether substitution is appropriate.
Composition and Active Ingredient
Brand: Venclax. Active ingredient: Venetoclax. Strength: 100 mg. Dosage form: Tablet. Therapeutic class: BCL-2 inhibitor. Listed manufacturer: Beacon Pharmaceuticals Ltd., Bangladesh. Packaging details should be confirmed on the manufacturer’s current pack.
Therapeutic Uses and Indications
Venetoclax is used in selected chronic lymphocytic leukemia and acute myeloid leukemia. These are generic-level clinical contexts and do not independently confirm every indication for this particular branded presentation. Eligibility may depend on biomarkers, previous therapy and country-specific labeling.
Mechanism of Action – How Venetoclax Works
Venetoclax inhibits antiapoptotic BCL-2. This mechanism alone does not establish suitability or effectiveness for an individual patient.
Dosage and Administration
The 100 mg shown is the strength of this tablet, not a recommended daily dose. Dose, timing, food instructions and treatment duration must be determined by the treating specialist using the current authorized prescribing information. Do not change dose or substitute brands or strengths without medical approval.
Contraindications
Contraindications depend on Venetoclax, formulation and individual medical conditions. Review the current official prescribing information, particularly hypersensitivity, pregnancy-related and organ-function restrictions.
Warnings and Precautions
Important safety considerations include tumor lysis syndrome and low blood counts. The prescriber may require laboratory testing, cardiac or organ-function assessment, and ongoing monitoring.
Possible Side Effects
Potential adverse effects and serious reactions include tumor lysis syndrome and low blood counts. Other reactions can occur. Consult the product leaflet for the full adverse-effect profile and seek medical care for severe symptoms.
Drug Interactions
Drug interactions may affect treatment effectiveness or toxicity. Inform the treating clinician of all prescriptions, over-the-counter products, herbal supplements and other treatments.
Pregnancy, Fertility and Breastfeeding
Some oncology and hematology medicines can cause fetal harm and require specific contraception or breastfeeding restrictions. Follow the medicine-specific official labeling and specialist advice.
Storage and Handling
Store according to the instructions printed on the actual Beacon Pharmaceuticals pack. Protect from inappropriate heat, humidity and light, and keep out of reach of children. Do not assume the storage conditions of another brand apply.
Why Is Venclax Listed as an Alternative to Venclexta?
The comparison helps identify another listed brand containing Venetoclax. It does not establish identical formulation, regulatory approval, bioequivalence or permission to substitute.
Manufacturer Information
Listed brand: Venclax. Manufacturer: Beacon Pharmaceuticals Ltd., Bangladesh. Reference brand: Venclexta. Generic: Venetoclax. Strength: 100 mg. Dosage form: Tablet.
Frequently Asked Questions
What is Venclax 100 mg? It is a tablet containing Venetoclax 100 mg according to the supplied Beacon price list. What is it used for? Venetoclax is used in selected chronic lymphocytic leukemia and acute myeloid leukemia, subject to specialist assessment. Can it replace Venclexta? Not automatically; a qualified professional must check product-specific equivalence and regulatory requirements. Is a prescription required? Yes, appropriate prescription and specialist supervision are necessary.
Important Medical Disclaimer
This listing is for educational pharmaceutical identification only and is not a substitute for medical advice, official product labeling or regulatory review. Brand, strength and pack details should be confirmed against the current manufacturer information before dispensing.
| Generic Name | Venetoclax |
|---|---|
| Strength | 100 mg |
| Manufacturer | Beacon Pharmaceuticals Ltd. |
Related products
Exjade 500 mg Alternative – Deferox (Deferasirox) 500 mg Tablet | Beacon Pharmaceuticals
Gleevec / Glivec 100 mg Alternative – Imacent (Imatinib) 100 mg Tablet | Incepta Pharmaceuticals
Imacent 100 mg (Imatinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Gleevec / Glivec (Novartis).
Pack: 30 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Reviews
There are no reviews yet.